Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
10.78
-0.08 (-0.74%)
Apr 28, 2026, 3:04 PM CST
SHE:002399 Market Cap
SHE:002399 has a market cap or net worth of 14.47 billion as of April 28, 2026. Its market cap has decreased by -5.70% in one year.
Market Cap
14.47B
Enterprise Value
14.66B
Revenue
5.48B
Ranking
n/a
PE Ratio
45.59
Stock Price
10.78
Market Cap Chart
Since May 6, 2010, SHE:002399's market cap has decreased from 70.09B to 14.47B, a decrease of -79.35%. That is a compound annual growth rate of -9.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 14.47B | -8.03% |
| Dec 31, 2025 | 15.73B | 11.19% |
| Dec 31, 2024 | 14.15B | -7.78% |
| Dec 29, 2023 | 15.34B | -10.21% |
| Dec 30, 2022 | 17.09B | -25.00% |
| Dec 31, 2021 | 22.79B | -3.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Kangtai Biological Products | 15.70B |
| Guangdong Zhongsheng Pharmaceutical | 15.60B |
| Shanghai Haoyuan Chemexpress | 15.20B |
| Nanjing King-Friend Biochemical Pharmaceutical | 15.04B |
| Beijing Aosaikang Pharmaceutical | 14.13B |
| Zhejiang Medicine | 13.80B |
| Guobang Pharma | 13.41B |
| Zhejiang Hisun Pharmaceutical | 13.20B |